Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?

Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Baek, Seungjae, Vithlani, Vatsal, Lad, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030660/
https://www.ncbi.nlm.nih.gov/pubmed/29926556
http://dx.doi.org/10.4046/trd.2018.0040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030660/
https://www.ncbi.nlm.nih.gov/pubmed/29926556
http://dx.doi.org/10.4046/trd.2018.0040

Ejemplares similares